IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q2 2024 Holdings

Filed 2024-08-14 | 13 holdings | $103.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$23.6M908,47422.8%
Blueprint Medicines Corp(2L9)COM09627Y109$12.4M114,60011.9%
Arvinas Inc(ARVN)COM04335A105$11.4M428,76611.0%
Regenxbio Inc(RGNX)COM75901B107$10.6M906,24810.2%
Kymera Therapeutics Inc(KYMR)COM501575104$9.8M328,7439.5%
Silence Therapeutics PLC(SLN)ADS82686Q101$9.5M500,2149.2%
Merus N VCOMN5749R100$8.8M148,1098.4%
Precision Biosciences Inc(DTIL)COM NEW74019P207$3.7M381,8033.6%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$3.2M156,6923.1%
Repare Therapeutics Inc(RPTX)COM760273102$3.2M956,9323.0%
Adicet BIO Inc(TORCEUR)COM007002108$3.1M2,531,1943.0%
Immatics N.v(IMTX)SHSN44445109$2.3M200,0002.2%
Sutro Biopharma IncCOM869367102$2.2M762,4982.2%